SWP
REGN icon

Stratos Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Stratos Wealth Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
372
-19
-5% -$12.9K ﹤0.01% 1551
2026
Q1 		$302K Buy
391
+25
+7% +$19.1K ﹤0.01% 1317
2025
Q4 		$283K Buy
+366
New +$249K ﹤0.01% 1324
2025
Q2 		– Sell
-506
Closed -$321K – 1469
2025
Q1 		$321K Sell
506
-115
-19% -$79.1K ﹤0.01% 1059
2024
Q4 		$442K Sell
621
-158
-20% -$133K 0.01% 990
2024
Q3 		$819K Buy
779
+108
+16% +$120K 0.01% 756
2024
Q2 		$705K Buy
671
+46
+7% +$44.6K 0.01% 776
2024
Q1 		$602K Buy
625
+202
+48% +$192K 0.01% 828
2023
Q4 		$372K Sell
423
-43
-9% -$35.4K 0.01% 989
2023
Q3 		$383K Buy
466
+106
+29% +$83.3K 0.01% 919
2023
Q2 		$259K Buy
360
+43
+14% +$33.2K 0.01% 1010
2023
Q1 		$260K Buy
317
+36
+13% +$27.2K 0.01% 932
2022
Q4 		$203K Sell
281
-13
-4% -$9.59K 0.01% 1044
2022
Q3 		$203K Buy
+294
New +$185K 0.01% 1018
2022
Q2 		– Sell
-535
Closed -$374K – 1285
2022
Q1 		$374K Buy
535
+16
+3% +$10.1K 0.01% 913
2021
Q4 		$328K Sell
519
-231
-31% -$142K 0.01% 970
2021
Q3 		$454K Buy
+750
New +$466K 0.01% 784
2020
Q3 		– Sell
-610
Closed -$380K – 1052
2020
Q2 		$380K Buy
+610
New +$346K 0.01% 693
2018
Q4 		– Sell
-31
Closed -$13K – 2121
2018
Q3 		$13K Buy
+31
New +$11.8K ﹤0.01% 2066
2018
Q2 		– Sell
-17
Closed -$6K – 2214
2018
Q1 		$6K Sell
17
-11
-39% -$3.83K ﹤0.01% 2554
2017
Q4 		$11K Buy
+28
New +$11.3K ﹤0.01% 2129
2017
Q3 		– Sell
-1,051
Closed -$516K – 954
2017
Q2 		$516K Sell
1,051
-1
-0.1% -$438 0.03% 443
2017
Q1 		$408K Buy
+1,052
New +$390K 0.02% 480

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Stratos Wealth Partners's REGN Position: Q2 2026 in Review

Stratos Wealth Partners reduced its Regeneron Pharmaceuticals (REGN) stake by 4.9% in Q2 2026, selling an estimated $12.9K and leaving 372 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

Stratos Wealth Partners first reported a position in REGN in Q1 2017 and has held it in 23 quarters since. The position peaked at $819K in Q3 2024. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Stratos Wealth Partners held 372 shares of Regeneron Pharmaceuticals worth $232K as of Q2 2026.
  • Stratos Wealth Partners sold 19 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $12.9K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Stratos Wealth Partners's portfolio in Q2 2026, its #1551 holding.
  • Stratos Wealth Partners first reported a position in Regeneron Pharmaceuticals in Q1 2017 and has held it in 23 quarters since.
  • Stratos Wealth Partners's Regeneron Pharmaceuticals position peaked at $819K in Q3 2024.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.